Article info
Original research
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance
- Correspondence to Dr Anna Fagotti, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy; anna.fagotti{at}policlinicogemelli.it
Citation
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance
Publication history
- Received March 15, 2022
- Accepted July 6, 2022
- First published July 22, 2022.
Article Versions
- You are currently viewing a Previous version of this article (22 July 2022).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.